RxDoctor Payments Data

Alexandra Lucas, PA

Physician Assistant · Hanover, MDNPI 1245011402

Payments from drug & device makers

$982in general payments, 2019–2025

Across 25 payments — averaging $39.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Teleflex LLC$303
  • Procept Biorobotics Corporation$280
  • Johnson & Johnson$92
  • Merck$86
  • Bayer$48
  • Astellas Pharma US Inc$43
  • plus $129 from 5 others

What the payments were for

  • Food & beverage$982100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$982 in reported general payments places this provider in the 75th percentile of 2,567 physician assistant providers in Maryland.

See all physician assistant providers in Maryland

Medicare billing

Part B allowed, 2024
$31,150
Medicare patients
214
Services billed
717

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MyrbetriqMirabegron32$18,769
GemtesaVibegron17$10,361
Estradiol51$3,735
Tamsulosin Hcl184$2,932
Finasteride105$1,440
Methenamine Hippurate16$1,331
Potassium Citrate ErPotassium Citrate13$608
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst38$368
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim69$225
Ciprofloxacin Hcl88$168
Alfuzosin Hcl ErAlfuzosin Hcl24$153
Levofloxacin39$74

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Astellas Pharma US IncMyrbetriq$43$18,76932 claims
Sumitomo Pharma America, Inc.Gemtesa$39$10,36117 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 2,567 physician assistant providers in Maryland.

Other physician assistant in Hanover

See the full list for Maryland

Where these figures come from

Is this you, or does something look wrong? →